424 related articles for article (PubMed ID: 16763013)
1. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
Boström E; Simonsson US; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
[TBL] [Abstract][Full Text] [Related]
2. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
Boström E; Hammarlund-Udenaes M; Simonsson US
Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
[TBL] [Abstract][Full Text] [Related]
3. Morphine brain pharmacokinetics at very low concentrations studied with accelerator mass spectrometry and liquid chromatography-tandem mass spectrometry.
Sadiq MW; Salehpour M; Forsgard N; Possnert G; Hammarlund-Udenaes M
Drug Metab Dispos; 2011 Feb; 39(2):174-9. PubMed ID: 21059857
[TBL] [Abstract][Full Text] [Related]
4. Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.
Sadiq MW; Boström E; Keizer R; Björkman S; Hammarlund-Udenaes M
J Pharm Sci; 2013 Sep; 102(9):3320-31. PubMed ID: 23463542
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
Bundgaard C; Jørgensen M; Larsen F
Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
[TBL] [Abstract][Full Text] [Related]
6. Brain distribution of cetirizine enantiomers: comparison of three different tissue-to-plasma partition coefficients: K(p), K(p,u), and K(p,uu).
Gupta A; Chatelain P; Massingham R; Jonsson EN; Hammarlund-Udenaes M
Drug Metab Dispos; 2006 Feb; 34(2):318-23. PubMed ID: 16303872
[TBL] [Abstract][Full Text] [Related]
7. Microdialysis evaluation of atomoxetine brain penetration and central nervous system pharmacokinetics in rats.
Kielbasa W; Kalvass JC; Stratford R
Drug Metab Dispos; 2009 Jan; 37(1):137-42. PubMed ID: 18936112
[TBL] [Abstract][Full Text] [Related]
8. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
Okura T; Higuchi K; Deguchi Y
Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
[TBL] [Abstract][Full Text] [Related]
9. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat.
Isakovic AJ; Abbott NJ; Redzic ZB
J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584
[TBL] [Abstract][Full Text] [Related]
10. Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study.
Bällgren F; Hammarlund-Udenaes M; Loryan I
Pharm Res; 2023 Nov; 40(11):2715-2730. PubMed ID: 37610619
[TBL] [Abstract][Full Text] [Related]
11. Modelling of the blood-brain barrier transport of morphine-3-glucuronide studied using microdialysis in the rat: involvement of probenecid-sensitive transport.
Xie R; Bouw MR; Hammarlund-Udenaes M
Br J Pharmacol; 2000 Dec; 131(8):1784-92. PubMed ID: 11139459
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of 3-quinuclidinyl 4-[125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies.
Sawada Y; Hiraga S; Francis B; Patlak C; Pettigrew K; Ito K; Owens E; Gibson R; Reba R; Eckelman W
J Cereb Blood Flow Metab; 1990 Nov; 10(6):781-807. PubMed ID: 2134838
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
15. Involvement of an influx transporter in the blood-brain barrier transport of naloxone.
Suzuki T; Ohmuro A; Miyata M; Furuishi T; Hidaka S; Kugawa F; Fukami T; Tomono K
Biopharm Drug Dispos; 2010 May; 31(4):243-52. PubMed ID: 20437463
[TBL] [Abstract][Full Text] [Related]
16. Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833.
Boström E; Simonsson US; Hammarlund-Udenaes M
J Pharm Sci; 2005 May; 94(5):1060-6. PubMed ID: 15799017
[TBL] [Abstract][Full Text] [Related]
17. Verapamil P-glycoprotein transport across the rat blood-brain barrier: cyclosporine, a concentration inhibition analysis, and comparison with human data.
Hsiao P; Sasongko L; Link JM; Mankoff DA; Muzi M; Collier AC; Unadkat JD
J Pharmacol Exp Ther; 2006 May; 317(2):704-10. PubMed ID: 16415090
[TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: potential involvement of a carrier-mediated mechanism.
Au-Yeung SC; Rurak DW; Gruber N; Riggs KW
Drug Metab Dispos; 2006 Jun; 34(6):955-60. PubMed ID: 16510542
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of oxycodone in children 6 months to 7 years old.
El-Tahtawy A; Kokki H; Reidenberg BE
J Clin Pharmacol; 2006 Apr; 46(4):433-42. PubMed ID: 16554451
[TBL] [Abstract][Full Text] [Related]
20. Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Fridén M; Winiwarter S; Jerndal G; Bengtsson O; Wan H; Bredberg U; Hammarlund-Udenaes M; Antonsson M
J Med Chem; 2009 Oct; 52(20):6233-43. PubMed ID: 19764786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
